# Codex review: medical_monitoring_daily_ai_assembly_gate_20260804

Date: 2026-08-04

## Verdict

**Pass for the declared offline frontend contract slice.**

The change is minimal and coherent: it makes the existing UI action consume the
same explicit AI progress evidence that the evidence card already displays. It
does not alter backend transitions or claim provider/runtime availability.

## Boundary check

- Changed production sources are limited to the daily-run view model and panel;
  the two frontend test files and derived `frontend/dist` are recorded.
- No backend, API, database, provider, service, browser, real project, B6/C14,
  source-token/CAS or medical-writing surface was touched.
- A read-only mtime scan saw an unrelated pre-existing medical-writing file
  change before this slice initialized; it was preserved and not included.
- Reserved ports remained stopped.

## Verification

- Focused Node assertions: **24** and **66** passed.
- All 31 medical-monitoring Node suites passed.
- Frontend monitoring Python contract: **30 passed**.
- Daily-run service/router regression: **52 passed**.
- Vite build: **1951 modules transformed, PASS**; only the pre-existing large
  chunk advisory remains.
- Current gates re-opened read-only and remain B6 `pending_review`, C14
  `blocked_pending_b6_review`, real-loop `blocked`.
- Hermes workflow `review-gate --require-verification` is required for this
  record and is run after the evidence files are complete.

## Review notes

- The gate requires an explicit completed submission step and strict non-negative
  integer counts; missing/malformed data is not coerced to zero.
- Terminal `completed`, `partial_completed` and `failed` ledgers may proceed to
  the existing backend assembly path, which then preserves its partial-analysis
  semantics. `running`/`queued`, count mismatch and unknown states cannot expose
  the action.
- The empty-job path is allowed only with an explicit `not_submitted` ledger whose
  total and all component counts are zero; absence of the ledger itself remains
  blocked.

## Residual risk

No real runtime or browser evidence exists for this slice. The product still
cannot be called commercially ready while the formal B6 reviewer outcome,
source-token/CAS, controlled runtime, five-project scientific/Playwright loop and
release dossier gates remain open.
